Clinical Trial Update: Reolysin in Combination With FOLFOX6 and Bevacizumab or FOLFOX6 and Bevacizumab Alone in Metastatic Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Reolysin in combination with FOLFOX6 and bevacizumab or FOLFOX6 and bevacizumab alone in metastatic colorectal cancer has completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• FOLFOX6
• REOLYSIN (pelareorep)

Snippet

Sponsor: Canadian Cancer Trials Group | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED | Results posted: 2019-12-13